Literature DB >> 19272281

Cluster headache, hypothalamus, and orexin.

Philip R Holland1, Peter J Goadsby.   

Abstract

Cluster headache (CH) is a highly disabling condition resulting in severe, recurrent unilateral bouts of pain and accompanying autonomic symptoms. This review describes some current views regarding the underlying pathophysiology covering the pain and cranial autonomic (parasympathetic) activation, and highlights the potential importance of the hypothalamus in CH. The hypothalamus is known to modulate many functions and has been shown to be involved in the pathophysiology of a variety of primary headaches, including CH. Hypothalamic structures are likely to underlie the circadian and circannual periodicity of attacks and contribute to the pain and autonomic disturbances. We discuss the hypothalamic involvement in CH and modulation of trigeminovascular processing and examine the emerging involvement of the hypothalamic orexinergic system as a possible key pathway in CH pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19272281     DOI: 10.1007/s11916-009-0025-x

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  55 in total

1.  Anatomical and functional demonstration of a multisynaptic suprachiasmatic nucleus adrenal (cortex) pathway.

Authors:  R M Buijs; J Wortel; J J Van Heerikhuize; M G Feenstra; G J Ter Horst; H J Romijn; A Kalsbeek
Journal:  Eur J Neurosci       Date:  1999-05       Impact factor: 3.386

2.  Orexin-A, an hypothalamic peptide with analgesic properties.

Authors:  S Bingham; P T Davey; A J Babbs; E A Irving; M J Sammons; M Wyles; P Jeffrey; L Cutler; I Riba; A Johns; R A Porter; N Upton; A J Hunter; A A Parsons
Journal:  Pain       Date:  2001-05       Impact factor: 6.961

3.  Oxytocin and electrical stimulation of the paraventricular hypothalamic nucleus produce antinociceptive effects that are reversed by an oxytocin antagonist.

Authors:  Yuritzia Miranda-Cardenas; Gerardo Rojas-Piloni; Guadalupe Martínez-Lorenzana; Javier Rodríguez-Jiménez; Mónica López-Hidalgo; Marie José Freund-Mercier; Miguel Condés-Lara
Journal:  Pain       Date:  2006-03-09       Impact factor: 6.961

4.  A genome-wide scan and HCRTR2 candidate gene analysis in a European cluster headache cohort.

Authors:  L Baumber; C Sjöstrand; M Leone; H Harty; G Bussone; J Hillert; R C Trembath; M B Russell
Journal:  Neurology       Date:  2006-06-27       Impact factor: 9.910

5.  Treatment of migraine attacks with a long-acting somatostatin analogue (octreotide, SMS 201-995).

Authors:  S Kapicioğlu; E Gökce; Z Kapicioğlu; E Ovali
Journal:  Cephalalgia       Date:  1997-02       Impact factor: 6.292

6.  Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception.

Authors:  P R Holland; S Akerman; P J Goadsby
Journal:  J Pharmacol Exp Ther       Date:  2005-09-13       Impact factor: 4.030

7.  Modulation of nociceptive dural input to the trigeminal nucleus caudalis via activation of the orexin 1 receptor in the rat.

Authors:  P R Holland; S Akerman; P J Goadsby
Journal:  Eur J Neurosci       Date:  2006-11       Impact factor: 3.386

8.  Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin.

Authors:  A N van den Pol; X B Gao; K Obrietan; T S Kilduff; A B Belousov
Journal:  J Neurosci       Date:  1998-10-01       Impact factor: 6.167

9.  Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area.

Authors:  T Bartsch; M J Levy; Y E Knight; P J Goadsby
Journal:  Pain       Date:  2004-06       Impact factor: 6.961

10.  Haplotype analysis confirms the association between the HCRTR2 gene and cluster headache.

Authors:  Innocenzo Rainero; Salvatore Gallone; Elisa Rubino; Paola Ponzo; Walter Valfre; Eleonora Binello; Pierpaola Fenoglio; Salvatore Gentile; Mihaela Anoaica; Mauro Gasparini; Lorenzo Pinessi
Journal:  Headache       Date:  2008-04-08       Impact factor: 5.887

View more
  22 in total

Review 1.  Traumatic head injury in cluster headache: cause or effect?

Authors:  Giorgio Lambru; Manjit Matharu
Journal:  Curr Pain Headache Rep       Date:  2012-04

Review 2.  Paroxysmal hemicrania: an update.

Authors:  Sanjay Prakash; Rushad Patell
Journal:  Curr Pain Headache Rep       Date:  2014-04

Review 3.  Licit and illicit drug use in cluster headache.

Authors:  Amelie Govare; Elizabeth Leroux
Journal:  Curr Pain Headache Rep       Date:  2014-05

4.  Migraine Therapy: Current Approaches and New Horizons.

Authors:  Peter J Goadsby; Philip R Holland
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

Review 5.  Sphenopalatine ganglion stimulation for the treatment of cluster headache.

Authors:  Miguel J A Láinez; Miguel Puche; Ana Garcia; Francisco Gascón
Journal:  Ther Adv Neurol Disord       Date:  2014-05       Impact factor: 6.570

Review 6.  Cluster headache with aura.

Authors:  Todd D Rozen
Journal:  Curr Pain Headache Rep       Date:  2011-04

7.  Heart rate variability in sleep-related migraine without aura.

Authors:  Catello Vollono; Valentina Gnoni; Elisa Testani; Serena Dittoni; Anna Losurdo; Salvatore Colicchio; Chiara Di Blasi; Salvatore Mazza; Benedetto Farina; Giacomo Della Marca
Journal:  J Clin Sleep Med       Date:  2013-07-15       Impact factor: 4.062

Review 8.  Cluster headache pathophysiology - insights from current and emerging treatments.

Authors:  Diana Y Wei; Peter J Goadsby
Journal:  Nat Rev Neurol       Date:  2021-03-29       Impact factor: 42.937

9.  Impact of continuing or quitting smoking on episodic cluster headache: a pilot survey.

Authors:  Anna Ferrari; Maurizio Zappaterra; Federica Righi; Michela Ciccarese; Ilaria Tiraferri; Luigi Alberto Pini; Simona Guerzoni; Maria Michela Cainazzo
Journal:  J Headache Pain       Date:  2013-06-06       Impact factor: 7.277

Review 10.  An overview of the orexinergic system in different animal species.

Authors:  Idris A Azeez; Olumayowa O Igado; James O Olopade
Journal:  Metab Brain Dis       Date:  2021-07-05       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.